Triploidy is a common chromosomal aberration seen in 1% of clinically
recognized human pregnancies. Development beyond 10 weeks is unusual.
Occasionally fetuses survive past 20 weeks; however, they usually pres
ent as a stillbirth with only a few managing some hours of independent
life. The clinical features of these infants cover a wide spectrum, b
ut a consistent feature is organ hypoplasia and hypotonia. We observed
marked enlargement of somatostatin-producing cells (D cells) in the p
ancreata of triploid fetuses. Somatostatin-producing cells are widely
distributed in normal mammals although concentrated in the pancreas an
d gastrointestinal tract, generally being antiproliferative and having
an inhibitory effect on various functions. The control of fetal growt
h is not well understood. There is, however, some evidence that somato
statin does play a significant part and our consistent observation of
cytomegaly of the pancreatic D cells in growth-retarded triploid fetus
es provides more support for this contention.